Involvement of extracellular vesicles in aging process and their beneficial effects in alleviating aging‐associated symptoms. (4th September 2021)

• Record Type: Journal Article
• Authors: Das, Madhurima; Kale, Vaijayanti
• Is Part Of: Cell biology international. Volume 45:Number 12(2021)
• Page Start: 2403
• Page End: 2419
• Publication Date: 2021-09-04
• Subjects: aging -- extracellular vesicles (EVs) -- mesenchymal stem cells (MCSs) -- rejuvenation -- stem cells; Cytology -- Periodicals; Cells -- Periodicals; 571.605
• DOI: 10.1002/cbin.11691
• Languages: English
• ISSNs: 1065-6995

Abstract

Abstract: Aging is a gradual and unavoidable physiological phenomenon that manifests in the natural maturation process and continues to progress from infanthood to adulthood. Many elderly people suffer from aging‐associated hematological and nonhematological disorders. Recent advances in regenerative medicine have shown new revolutionary paths of treating such diseases using stem cells; however, aging also affects the quality and competence of stem and progenitor cells themselves and ultimately directs their death or apoptosis and senescence, leading to a decline in their regenerative potential. Recent research works show that extracellular vesicles (EVs) isolated from different types of stem cells may provide a safe treatment for aging‐associated disorders. The cargo of EVs comprises packets of information in the form of various macromolecules that can modify the fate of the target cells. To harness the true potential of EVs in regenerative medicine, it is necessary to understand how this cargo contributes to the rejuvenation of aged stem and progenitor populations and to identify the aging‐associated changes in the macromolecular profile of the EVs themselves. In this review, we endeavor to summarize the current knowledge of the involvement of EVs in the aging process and delineate the role of EVs in the reversal of aging‐associated phenotypes. We have also analyzed the involvement of the molecular cargo of EVs in the generation of aging‐associated disorders. This knowledge could not only help us in understanding the mechanism of the aging process but could also facilitate the development of new cell‐free biologics to treat aging‐related disorders in the future.